Imexpharm

Imexpharm Retained Earnings

The Retained Earnings of Imexpharm (IMP.VN) as of Oct 27, 2026 is 449.01 B VND. In the previous year, Retained Earnings was 320.81 B VND — a change of 39.96% (higher).

Retained Earnings

449.01 BVND

YoY

39.96%

Last updated:

Retained Earnings of Imexpharm is 2025 449.01 B VND. Retained Earnings of Imexpharm was 2024 320.81 B VND. It decreases by 39.96% higher compared to the previous year.

The Imexpharm Retained Earnings history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Retained Earnings
Date
Retained Earnings
Jan 1, 2018
125.09 B VND
Jan 1, 2019
461.37 B VND
Jan 1, 2020
554.00 B VND
Jan 1, 2021
617.93 B VND
Jan 1, 2022
264.65 B VND
Jan 1, 2023
440.10 B VND
Jan 1, 2024
320.81 B VND
Jan 1, 2025
449.01 B VND
The Imexpharm Retained Earnings history
YEARRetained EarningsYoY
449.01 BVND+39.96%
320.81 BVND-27.11%
440.10 BVND+66.30%
264.65 BVND-57.17%
617.93 BVND+11.54%
554.00 BVND+20.08%
461.37 BVND+268.83%
125.09 BVND+29.92%
96.28 BVND+5.16%
91.55 BVND+7.65%
85.05 BVND+6.01%
80.23 BVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

Retained Earnings of Imexpharm is 449.01 B VND in 2025.

Retained Earnings of Imexpharm changed from 320.81 B VND to 449.01 B VND, representing a 39.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Retained Earnings Imexpharm since 2006 – with annual values, charts, and detailed analysis.

Retained earnings are the cumulative net income kept in the business rather than paid out as dividends. They fund future growth and operations.

Retained Earnings's VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Retained Earnings's Imexpharm historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Imexpharm

All Key Metrics — Imexpharm